Patents Assigned to Elan PharmaceuticalsTechnologies, Inc.
  • Peptide-lipid conjugates, liposomes and lipsomal drug delivery
    Patent number: 6339069
    Abstract: Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
    Type: Grant
    Filed: June 29, 1999
    Date of Patent: January 15, 2002
    Assignee: Elan PharmaceuticalsTechnologies, Inc.
    Inventors: Paul R. Meers, Charles Pak, Shaukat Ali, Andrew Janoff, J. Craig Franklin, Ravi K. Erukulla, Donna Cabral-Lilly, Patrick L. Ahl